Let’s look at the key reasons that are pushing Adaptive Biotechnologies Corp (ADPT) to new highs

On Friday, Adaptive Biotechnologies Corp (NASDAQ: ADPT) was 3.29% up from the session before settling in for the closing price of $6.07. A 52-week range for ADPT has been $2.28 – $6.70.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.

Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!

Get the FREE Report with all the details here.


Sponsored

Over the past five-year period, the growth rate of yearbook sales for the company of the Healthcare sector was 27.46%. When this article was written, the company’s average yearly earnings per share was at 28.53%. With a float of $142.73 million, this company’s outstanding shares have now reached $147.56 million.

Considering the fact that the conglomerate employs 709 people, you should pay attention to its efficiency factor. In terms of profitability, gross margin is 53.84%, operating margin of -93.9%, and the pretax margin is -110.17%.

Adaptive Biotechnologies Corp (ADPT) Breakdown of a Key Holders of the stock

Also, it is sometimes useful to examine the sentiment of large-scale investors toward Adaptive Biotechnologies Corp stocks. The insider ownership of Adaptive Biotechnologies Corp is 3.29%, while institutional ownership is 92.21%. The most recent insider transaction that took place on Nov 18 ’24, was worth 1,235. In this transaction Chief Financial Officer of this company sold 248 shares at a rate of $4.98, taking the stock ownership to the 154,330 shares. Before that another transaction happened on Aug 22 ’24, when Company’s SVP and General Counsel sold 26,922 for $4.50, making the entire transaction worth $121,079. This insider now owns 139,365 shares in total.

Adaptive Biotechnologies Corp (ADPT) Recent Fiscal highlights

According to the Wall Street analysts, stocks earnings will be around 28.53% per share during the next fiscal year.

Adaptive Biotechnologies Corp (NASDAQ: ADPT) Trading Performance Indicators

You can see what Adaptive Biotechnologies Corp (ADPT) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 3.38. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 5.39.

For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.34, a number that is poised to hit -0.26 in the next quarter and is forecasted to reach -0.93 in one year’s time.

Technical Analysis of Adaptive Biotechnologies Corp (ADPT)

Compared to the last year’s volume of 1.42 million, its volume of 1.16 million showed lagged in the last five days. As of the previous 9 days, the stock’s Stochastic %D was 80.74%. Additionally, its Average True Range was 0.43.

During the past 100 days, Adaptive Biotechnologies Corp’s (ADPT) raw stochastic average was set at 84.94%, which indicates a significant decrease from 86.77% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 98.81% in the past 14 days, which was higher than the 80.73% volatility it showed in the past 100 days.

At the time of writing, stock’s 50-day Moving Average is $5.24, while its 200-day Moving Average is $4.10. Nevertheless, the first resistance level for the watch stands at $6.40 in the near term. At $6.53, the stock is likely to face the second major resistance level. The third major resistance level sits at $6.72. If the price goes on to break the first support level at $6.09, it is likely to go to the next support level at $5.90. Now, if the price goes above the second support level, the third support stands at $5.77.

Adaptive Biotechnologies Corp (NASDAQ: ADPT) Key Stats

There are 147,579K outstanding shares of the company, which has a market capitalization of 955.81 million. As of now, sales total 170,280 K while income totals -225,250 K. Its latest quarter income was 46,440 K while its last quarter net income were -32,070 K.